Theorem partners up for patient testing

Theorem Clinical Research has signed a deal with Biomedical Systems to expand its testing services, enlisting a partner with expertise in diagnostics.

Theorem CEO John Potthoff

Headquartered in St. Louis, Biomedical Systems specializes in providing sponsors and CROs with a broad range of diagnostic tests used in clinical trials. Through the partnership, Theorem and its clients get access to the company's fleet of testing services, while Biomedical Systems gains access to new markets through the CRO's expansive reach.

"Biomedical Systems is one of the true pioneers in our industry, supervising breakthrough research innovations in centralized cardiac safety, pulmonary function, imaging, scientific affairs and electronic clinical outcome assessment (eCOA)," Theorem CEO John Potthoff said in a statement. "The company's broad range of capabilities and global scale are a complement to Theorem studies being conducted around the world."

The agreement follows a slew of partnerships for the expansion-minded Theorem. Over the past 18 months, the Pennsylvania CRO has signed a deal with India's Excel Life Sciences to broaden its footprint in that country, joined Decision Driver Analytics to expand its post-market efforts, teamed up with Charles River Laboratories ($CRL) on preclinical research and reached out to Emergo to better capitalize on med tech.

- read the statement

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.